English

VANTAGEMED CORP

EDGAR

Filing (10KSB) · filed 2007-04-02

31 filing records in this dataset, filed from 2000-03-30 to 2007-04-02. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.87 million USD

2006-12-31 · USD

Exact inputs and evidence

Revenue: 10960000 USD Source
Revenue: 8095000 USD Source

Operating margin

5.13%

2006-12-31 · %

Exact inputs and evidence

Operating Income: -1138000 USD Source
Operating Income: -1285000 USD Source
Revenue: 10960000 USD Source
Revenue: 8095000 USD Source

Operating cash flow

405 thousand USD

2006-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -702000 USD Source
Operating Cash Flow: -1107000 USD Source

Free cash flow

404 thousand USD

2006-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -702000 USD Source
Operating Cash Flow: -1107000 USD Source
Capital Expenditure: 29000 USD Source
Capital Expenditure: 28000 USD Source

Cash and cash equivalents: 820 thousand USD 2006-12-31 Source
Exact value

820000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

11 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Revenue: 2924000 USD · 2006-01-01 – 2006-03-31 Source
Revenue: 2556000 USD · 2006-04-01 – 2006-06-30 Source
Revenue: 2614000 USD · 2006-07-01 – 2006-09-30 Source
Revenue: 10960000 USD · 2006-01-01 – 2006-12-31 Source
Revenue: 8095000 USD · 2006-01-01 – 2006-09-30 Source

Net income

-983 thousand USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Net income: -390000 USD · 2006-01-01 – 2006-03-31 Source
Net income: -506000 USD · 2006-04-01 – 2006-06-30 Source
Net income: -232000 USD · 2006-07-01 – 2006-09-30 Source
Net income: -983000 USD · 2006-01-01 – 2006-12-31 Source
Net income: -1128000 USD · 2006-01-01 – 2006-09-30 Source

Operating cash flow

-702 thousand USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Operating cash flow: -695000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -1062000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -695000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -1107000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: -1062000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -702000 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: -1107000 USD · 2006-01-01 – 2006-09-30 Source

Capital expenditure

29 thousand USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Capital expenditure: 14000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 27000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 14000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 28000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 27000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 29000 USD · 2006-01-01 – 2006-12-31 Source
Capital expenditure: 28000 USD · 2006-01-01 – 2006-09-30 Source

Free cash flow

-731 thousand USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Operating cash flow: -695000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -1062000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -695000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -1107000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: -1062000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -702000 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: -1107000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 14000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 27000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 14000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 28000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 27000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 29000 USD · 2006-01-01 – 2006-12-31 Source
Capital expenditure: 28000 USD · 2006-01-01 – 2006-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2007-04-02.

Financial data available through: 2006-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2006-12-31
Operating income: 10 of 11 periods available· newest 2006-12-31
Net income: 10 of 11 periods available· newest 2006-12-31
Operating cash flow: 10 of 11 periods available· newest 2006-12-31
Capital expenditure: 10 of 11 periods available· newest 2006-12-31
Total assets: 9 of 11 periods available· newest 2006-12-31
Total liabilities: 9 of 11 periods available· newest 2006-12-31
Current assets: 9 of 11 periods available· newest 2006-12-31
Current liabilities: 9 of 11 periods available· newest 2006-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2006-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-28.3%

Prior period

USD 15.3 million

2005-01-01 – 2005-12-31
Current period

USD 10.96 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

10960000 − 15295000 = -4335000 USD

15295000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
10960000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · VANTAGEMED CORP · 2006-12-31 VANTAGEMED CORP (edgar:1099531) Year-over-year change in Revenue: -4335000 USD Concept: fundies:Revenue Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 10960000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#6314 Input fundies:Revenue: 15295000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#6314
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 3.3 million

Prior period

−USD 4.28 million

2005-01-01 – 2005-12-31
Current period

−USD 983,000

2006-01-01 – 2006-12-31

Exact inputs and evidence

-983000 − -4280000 = 3297000 USD

-4280000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
-983000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · VANTAGEMED CORP · 2006-12-31 VANTAGEMED CORP (edgar:1099531) Year-over-year change in Net income: 3297000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -983000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8307 Input fundies:NetIncome: -4280000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8307
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 3.91 million

Prior period

−USD 4.61 million

2005-01-01 – 2005-12-31
Current period

−USD 702,000

2006-01-01 – 2006-12-31

Exact inputs and evidence

-702000 − -4611000 = 3909000 USD

-4611000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
-702000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · VANTAGEMED CORP · 2006-12-31 VANTAGEMED CORP (edgar:1099531) Year-over-year change in Operating cash flow: 3909000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -702000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8555 Input fundies:OperatingCashFlow: -4611000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8555
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-40.8%

Prior period

USD 49,000

2005-01-01 – 2005-12-31
Current period

USD 29,000

2006-01-01 – 2006-12-31

Exact inputs and evidence

29000 − 49000 = -20000 USD

49000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
29000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · VANTAGEMED CORP · 2006-12-31 VANTAGEMED CORP (edgar:1099531) Year-over-year change in Capital expenditure: -20000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 29000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8596 Input fundies:CapitalExpenditure: 49000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8596
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2006 2006-01-01 – 2006-12-31

Revenue USD 10.96 million 100% of revenue
Cost of revenue USD 5.34 million 49% of revenue
Operating expenses USD 6.76 million 62% of revenue
Operating income −USD 1.14 million −10% of revenue
Tax, interest and other Derived −USD 155,000 −1.4% of revenue
Net income −USD 983,000 −9% of revenue

Cash

Operating cash flow −USD 702,000 −6.4% of revenue
Capital expenditure USD 29,000 0.3% of revenue
Free cash flow Derived −USD 731,000 −6.7% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1997 Operating loss: operating costs were 112% of revenue.
1998 Operating loss: operating costs were 143% of revenue.
1999 Operating loss: operating costs were 148% of revenue.
2000 Operating loss: operating costs were 220% of revenue.
2001 Operating loss: operating costs were 164% of revenue.
2002 Operating loss: operating costs were 137% of revenue.
2003 Operating loss: operating costs were 114% of revenue.
2004 Operating loss: operating costs were 117% of revenue.
2005 Operating loss: operating costs were 128% of revenue.
2006 Operating loss: operating costs were 110% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1997 1997-01-01 – 1997-12-31	5248000	5857000 Derived	-609000	-175000 Derived	-434000	-882000 Derived	Source 1997-01-01 – 1997-12-31: 5248000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -609000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -434000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -611000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 271000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	9373000	13403000 Derived	-4030000	207000 Derived	-4237000	-1935000 Derived	Source 1998-01-01 – 1998-12-31: 9373000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -4030000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -4237000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -298000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1637000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	19412000	28679000 Derived	-9267000	948000 Derived	-10215000	-9828000 Derived	Source 1999-01-01 – 1999-12-31: 19412000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -9267000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -10215000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -9302000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 526000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	23907000	52644000 Derived	-28737000	2300000 Derived	-31037000	-9979000 Derived	Source 2000-01-01 – 2000-12-31: 23907000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -28737000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -31037000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -9486000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 493000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	23935000	39211000 Derived	-15276000	701000 Derived	-15977000	-7427000 Derived	Source 2001-01-01 – 2001-12-31: 23935000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -15276000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -15977000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -7175000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 252000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	21744000	29797000 Derived	-8053000	-7000 Derived	-8046000	-5578000 Derived	Source 2002-01-01 – 2002-12-31: 21744000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -8053000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -8046000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -5407000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 171000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	21855000	25002000 Derived	-3147000	-10000 Derived	-3137000	-1109000 Derived	Source 2003-01-01 – 2003-12-31: 21855000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -3147000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -3137000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -815000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 294000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	22120000	25928000 Derived	-3808000	97000 Derived	-3905000	-878000 Derived	Source 2004-01-01 – 2004-12-31: 22120000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -3808000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -3905000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -747000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 131000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	15295000	19568000 Derived	-4273000	7000 Derived	-4280000	-4660000 Derived	Source 2005-01-01 – 2005-12-31: 15295000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -4273000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -4280000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -4611000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 49000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	10960000	12098000 Derived	-1138000	-155000 Derived	-983000	-731000 Derived	Source 2006-01-01 – 2006-12-31: 10960000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -1138000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -983000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -702000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 29000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 11M 2006

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Revenue	5248000	Revenue: 5248000 Open source
19981998-12-31	Revenue	9373000	Revenue: 9373000 Open source
19991999-12-31	Revenue	19412000	Revenue: 19412000 Open source
20002000-12-31	Revenue	23907000	Revenue: 23907000 Open source
20012001-12-31	Revenue	23935000	Revenue: 23935000 Open source
20022002-12-31	Revenue	21744000	Revenue: 21744000 Open source
20032003-12-31	Revenue	21855000	Revenue: 21855000 Open source
20042004-12-31	Revenue	22120000	Revenue: 22120000 Open source
20052005-12-31	Revenue	15295000	Revenue: 15295000 Open source
20062006-12-31	Revenue	10960000	Revenue: 10960000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-28.3% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Year over year	No prior comparable period	Revenue: 5248000 Open source
19981998-12-31	Year over year	78.6%	Revenue: 9373000 Open source Revenue: 5248000 Open source
19991999-12-31	Year over year	107.1%	Revenue: 19412000 Open source Revenue: 9373000 Open source
20002000-12-31	Year over year	23.2%	Revenue: 23907000 Open source Revenue: 19412000 Open source
20012001-12-31	Year over year	0.1%	Revenue: 23935000 Open source Revenue: 23907000 Open source
20022002-12-31	Year over year	-9.2%	Revenue: 21744000 Open source Revenue: 23935000 Open source
20032003-12-31	Year over year	0.5%	Revenue: 21855000 Open source Revenue: 21744000 Open source
20042004-12-31	Year over year	1.2%	Revenue: 22120000 Open source Revenue: 21855000 Open source
20052005-12-31	Year over year	-30.9%	Revenue: 15295000 Open source Revenue: 22120000 Open source
20062006-12-31	Year over year	-28.3%	Revenue: 10960000 Open source Revenue: 15295000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -10.4% 2006

Net margin -9% 2006

Free cash flow margin -6.7% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Operating margin	-11.6%	Operating Income: -609000 Open source Revenue: 5248000 Open source
19981998-12-31	Operating margin	-43%	Operating Income: -4030000 Open source Revenue: 9373000 Open source
19991999-12-31	Operating margin	-47.7%	Operating Income: -9267000 Open source Revenue: 19412000 Open source
20002000-12-31	Operating margin	-120.2%	Operating Income: -28737000 Open source Revenue: 23907000 Open source
20012001-12-31	Operating margin	-63.8%	Operating Income: -15276000 Open source Revenue: 23935000 Open source
20022002-12-31	Operating margin	-37%	Operating Income: -8053000 Open source Revenue: 21744000 Open source
20032003-12-31	Operating margin	-14.4%	Operating Income: -3147000 Open source Revenue: 21855000 Open source
20042004-12-31	Operating margin	-17.2%	Operating Income: -3808000 Open source Revenue: 22120000 Open source
20052005-12-31	Operating margin	-27.9%	Operating Income: -4273000 Open source Revenue: 15295000 Open source
20062006-12-31	Operating margin	-10.4%	Operating Income: -1138000 Open source Revenue: 10960000 Open source
19971997-12-31	Net margin	-8.3%	Net Income: -434000 Open source Revenue: 5248000 Open source
19981998-12-31	Net margin	-45.2%	Net Income: -4237000 Open source Revenue: 9373000 Open source
19991999-12-31	Net margin	-52.6%	Net Income: -10215000 Open source Revenue: 19412000 Open source
20002000-12-31	Net margin	-129.8%	Net Income: -31037000 Open source Revenue: 23907000 Open source
20012001-12-31	Net margin	-66.8%	Net Income: -15977000 Open source Revenue: 23935000 Open source
20022002-12-31	Net margin	-37%	Net Income: -8046000 Open source Revenue: 21744000 Open source
20032003-12-31	Net margin	-14.4%	Net Income: -3137000 Open source Revenue: 21855000 Open source
20042004-12-31	Net margin	-17.7%	Net Income: -3905000 Open source Revenue: 22120000 Open source
20052005-12-31	Net margin	-28%	Net Income: -4280000 Open source Revenue: 15295000 Open source
20062006-12-31	Net margin	-9%	Net Income: -983000 Open source Revenue: 10960000 Open source
19971997-12-31	Free cash flow margin	-16.8%	Revenue: 5248000 Open source Operating Cash Flow: -611000 Open source Capital Expenditure: 271000 Open source
19981998-12-31	Free cash flow margin	-20.6%	Revenue: 9373000 Open source Operating Cash Flow: -298000 Open source Capital Expenditure: 1637000 Open source
19991999-12-31	Free cash flow margin	-50.6%	Revenue: 19412000 Open source Operating Cash Flow: -9302000 Open source Capital Expenditure: 526000 Open source
20002000-12-31	Free cash flow margin	-41.7%	Revenue: 23907000 Open source Operating Cash Flow: -9486000 Open source Capital Expenditure: 493000 Open source
20012001-12-31	Free cash flow margin	-31%	Revenue: 23935000 Open source Operating Cash Flow: -7175000 Open source Capital Expenditure: 252000 Open source
20022002-12-31	Free cash flow margin	-25.7%	Revenue: 21744000 Open source Operating Cash Flow: -5407000 Open source Capital Expenditure: 171000 Open source
20032003-12-31	Free cash flow margin	-5.1%	Revenue: 21855000 Open source Operating Cash Flow: -815000 Open source Capital Expenditure: 294000 Open source
20042004-12-31	Free cash flow margin	-4%	Revenue: 22120000 Open source Operating Cash Flow: -747000 Open source Capital Expenditure: 131000 Open source
20052005-12-31	Free cash flow margin	-30.5%	Revenue: 15295000 Open source Operating Cash Flow: -4611000 Open source Capital Expenditure: 49000 Open source
20062006-12-31	Free cash flow margin	-6.7%	Revenue: 10960000 Open source Operating Cash Flow: -702000 Open source Capital Expenditure: 29000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -702K 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Operating cash flow	-611000	Operating Cash Flow: -611000 Open source
19981998-12-31	Operating cash flow	-298000	Operating Cash Flow: -298000 Open source
19991999-12-31	Operating cash flow	-9302000	Operating Cash Flow: -9302000 Open source
20002000-12-31	Operating cash flow	-9486000	Operating Cash Flow: -9486000 Open source
20012001-12-31	Operating cash flow	-7175000	Operating Cash Flow: -7175000 Open source
20022002-12-31	Operating cash flow	-5407000	Operating Cash Flow: -5407000 Open source
20032003-12-31	Operating cash flow	-815000	Operating Cash Flow: -815000 Open source
20042004-12-31	Operating cash flow	-747000	Operating Cash Flow: -747000 Open source
20052005-12-31	Operating cash flow	-4611000	Operating Cash Flow: -4611000 Open source
20062006-12-31	Operating cash flow	-702000	Operating Cash Flow: -702000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -731K 2006

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Free cash flow	-882000	Operating Cash Flow: -611000 Open source Capital Expenditure: 271000 Open source
19981998-12-31	Free cash flow	-1935000	Operating Cash Flow: -298000 Open source Capital Expenditure: 1637000 Open source
19991999-12-31	Free cash flow	-9828000	Operating Cash Flow: -9302000 Open source Capital Expenditure: 526000 Open source
20002000-12-31	Free cash flow	-9979000	Operating Cash Flow: -9486000 Open source Capital Expenditure: 493000 Open source
20012001-12-31	Free cash flow	-7427000	Operating Cash Flow: -7175000 Open source Capital Expenditure: 252000 Open source
20022002-12-31	Free cash flow	-5578000	Operating Cash Flow: -5407000 Open source Capital Expenditure: 171000 Open source
20032003-12-31	Free cash flow	-1109000	Operating Cash Flow: -815000 Open source Capital Expenditure: 294000 Open source
20042004-12-31	Free cash flow	-878000	Operating Cash Flow: -747000 Open source Capital Expenditure: 131000 Open source
20052005-12-31	Free cash flow	-4660000	Operating Cash Flow: -4611000 Open source Capital Expenditure: 49000 Open source
20062006-12-31	Free cash flow	-731000	Operating Cash Flow: -702000 Open source Capital Expenditure: 29000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

286.5% 2006

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1997-12-31	Liabilities / assets	Not reported	No source recorded
19981998-12-31	Liabilities / assets	73.6%	Total Liabilities: 8133000 Open source Total Assets: 11051000 Open source
19991999-12-31	Liabilities / assets	43.8%	Total Liabilities: 15972000 Open source Total Assets: 36464000 Open source
20002000-12-31	Liabilities / assets	21.6%	Total Liabilities: 7391000 Open source Total Assets: 34189000 Open source
20012001-12-31	Liabilities / assets	39.4%	Total Liabilities: 7015000 Open source Total Assets: 17806000 Open source
20022002-12-31	Liabilities / assets	73%	Total Liabilities: 7270000 Open source Total Assets: 9964000 Open source
20032003-12-31	Liabilities / assets	106.3%	Total Liabilities: 8121000 Open source Total Assets: 7638000 Open source
20042004-12-31	Liabilities / assets	207.9%	Total Liabilities: 8212000 Open source Total Assets: 3950000 Open source
20052005-12-31	Liabilities / assets	223.4%	Total Liabilities: 6174000 Open source Total Assets: 2764000 Open source
20062006-12-31	Liabilities / assets	286.5%	Total Liabilities: 5377000 Open source Total Assets: 1877000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.33× 2006

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1997-12-31	Current assets / current liabilities	Not reported	No source recorded
19981998-12-31	Current assets / current liabilities	0.29×	Current Assets: 1849000 Open source Current Liabilities: 6412000 Open source
19991999-12-31	Current assets / current liabilities	0.4×	Current Assets: 5321000 Open source Current Liabilities: 13333000 Open source
20002000-12-31	Current assets / current liabilities	3.08×	Current Assets: 19237000 Open source Current Liabilities: 6236000 Open source
20012001-12-31	Current assets / current liabilities	1.68×	Current Assets: 10222000 Open source Current Liabilities: 6091000 Open source
20022002-12-31	Current assets / current liabilities	0.87×	Current Assets: 5239000 Open source Current Liabilities: 6008000 Open source
20032003-12-31	Current assets / current liabilities	0.71×	Current Assets: 5367000 Open source Current Liabilities: 7554000 Open source
20042004-12-31	Current assets / current liabilities	0.4×	Current Assets: 3219000 Open source Current Liabilities: 8119000 Open source
20052005-12-31	Current assets / current liabilities	0.36×	Current Assets: 2174000 Open source Current Liabilities: 6110000 Open source
20062006-12-31	Current assets / current liabilities	0.33×	Current Assets: 1787000 Open source Current Liabilities: 5345000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1997 1997-01-01 – 1997-12-31	−USD 434,000 Exact value Exact value: -434000 USD 1997-01-01 – 1997-12-31: -434000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 1997-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -434000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -434000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-00-015064.txt#2736 The citation records this snapshot. The page link may show a newer release later.	−USD 611,000 Exact value Exact value: -611000 USD 1997-01-01 – 1997-12-31: -611000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 1997-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -611000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -611000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-00-015064.txt#2754 The citation records this snapshot. The page link may show a newer release later.	USD 271,000 Exact value Exact value: 271000 USD 1997-01-01 – 1997-12-31: 271000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 1997-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 271000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 271000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-00-015064.txt#2758 The citation records this snapshot. The page link may show a newer release later.	−USD 882,000 Calculation and evidence -611000 − 271000 USD Exact free cash flow: -882000 USD 1997-01-01 – 1997-12-31: -611000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 271000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 1997-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -882000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -611000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-00-015064.txt#2754 Input fundies:CapitalExpenditure: 271000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-00-015064.txt#2758 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 4.24 million Exact value Exact value: -4237000 USD 1998-01-01 – 1998-12-31: -4237000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 1998-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -4237000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4237000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-01-505886.txt#2667 The citation records this snapshot. The page link may show a newer release later.	−USD 298,000 Exact value Exact value: -298000 USD 1998-01-01 – 1998-12-31: -298000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 1998-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -298000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -298000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-01-505886.txt#2686 The citation records this snapshot. The page link may show a newer release later.	USD 1.64 million Exact value Exact value: 1637000 USD 1998-01-01 – 1998-12-31: 1637000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 1998-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 1637000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1637000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-01-505886.txt#2690 The citation records this snapshot. The page link may show a newer release later.	−USD 1.94 million Calculation and evidence -298000 − 1637000 USD Exact free cash flow: -1935000 USD 1998-01-01 – 1998-12-31: -298000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1637000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 1998-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -1935000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -298000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-01-505886.txt#2686 Input fundies:CapitalExpenditure: 1637000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-01-505886.txt#2690 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 10.22 million Exact value Exact value: -10215000 USD 1999-01-01 – 1999-12-31: -10215000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 1999-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -10215000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10215000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6511 The citation records this snapshot. The page link may show a newer release later.	−USD 9.3 million Exact value Exact value: -9302000 USD 1999-01-01 – 1999-12-31: -9302000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 1999-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -9302000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9302000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6773 The citation records this snapshot. The page link may show a newer release later.	USD 526,000 Exact value Exact value: 526000 USD 1999-01-01 – 1999-12-31: 526000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 1999-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 526000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 526000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6810 The citation records this snapshot. The page link may show a newer release later.	−USD 9.83 million Calculation and evidence -9302000 − 526000 USD Exact free cash flow: -9828000 USD 1999-01-01 – 1999-12-31: -9302000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 526000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 1999-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -9828000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9302000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6773 Input fundies:CapitalExpenditure: 526000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6810 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 31.04 million Exact value Exact value: -31037000 USD 2000-01-01 – 2000-12-31: -31037000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 2000-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -31037000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31037000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6511 The citation records this snapshot. The page link may show a newer release later.	−USD 9.49 million Exact value Exact value: -9486000 USD 2000-01-01 – 2000-12-31: -9486000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 2000-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -9486000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9486000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6773 The citation records this snapshot. The page link may show a newer release later.	USD 493,000 Exact value Exact value: 493000 USD 2000-01-01 – 2000-12-31: 493000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 2000-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 493000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 493000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6810 The citation records this snapshot. The page link may show a newer release later.	−USD 9.98 million Calculation and evidence -9486000 − 493000 USD Exact free cash flow: -9979000 USD 2000-01-01 – 2000-12-31: -9486000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 493000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 2000-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -9979000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9486000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6773 Input fundies:CapitalExpenditure: 493000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0000912057-02-020361.txt#6810 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 15.98 million Exact value Exact value: -15977000 USD 2001-01-01 – 2001-12-31: -15977000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 2001-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -15977000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15977000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-03-011116.txt#4836 The citation records this snapshot. The page link may show a newer release later.	−USD 7.18 million Exact value Exact value: -7175000 USD 2001-01-01 – 2001-12-31: -7175000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 2001-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -7175000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7175000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-03-011116.txt#4997 The citation records this snapshot. The page link may show a newer release later.	USD 252,000 Exact value Exact value: 252000 USD 2001-01-01 – 2001-12-31: 252000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 2001-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 252000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 252000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-03-011116.txt#5026 The citation records this snapshot. The page link may show a newer release later.	−USD 7.43 million Calculation and evidence -7175000 − 252000 USD Exact free cash flow: -7427000 USD 2001-01-01 – 2001-12-31: -7175000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 252000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 2001-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -7427000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7175000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-03-011116.txt#4997 Input fundies:CapitalExpenditure: 252000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-03-011116.txt#5026 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 8.05 million Exact value Exact value: -8046000 USD 2002-01-01 – 2002-12-31: -8046000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 2002-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -8046000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8046000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-04-010115.txt#4941 The citation records this snapshot. The page link may show a newer release later.	−USD 5.41 million Exact value Exact value: -5407000 USD 2002-01-01 – 2002-12-31: -5407000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 2002-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -5407000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5407000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-04-010115.txt#5091 The citation records this snapshot. The page link may show a newer release later.	USD 171,000 Exact value Exact value: 171000 USD 2002-01-01 – 2002-12-31: 171000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 2002-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 171000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 171000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-04-010115.txt#5124 The citation records this snapshot. The page link may show a newer release later.	−USD 5.58 million Calculation and evidence -5407000 − 171000 USD Exact free cash flow: -5578000 USD 2002-01-01 – 2002-12-31: -5407000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 171000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 2002-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -5578000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5407000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-04-010115.txt#5091 Input fundies:CapitalExpenditure: 171000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001047469-04-010115.txt#5124 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 3.14 million Exact value Exact value: -3137000 USD 2003-01-01 – 2003-12-31: -3137000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 2003-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -3137000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3137000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-05-013837.txt#9305 The citation records this snapshot. The page link may show a newer release later.	−USD 815,000 Exact value Exact value: -815000 USD 2003-01-01 – 2003-12-31: -815000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 2003-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -815000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -815000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-05-013837.txt#9572 The citation records this snapshot. The page link may show a newer release later.	USD 294,000 Exact value Exact value: 294000 USD 2003-01-01 – 2003-12-31: 294000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 2003-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 294000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 294000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-05-013837.txt#9613 The citation records this snapshot. The page link may show a newer release later.	−USD 1.11 million Calculation and evidence -815000 − 294000 USD Exact free cash flow: -1109000 USD 2003-01-01 – 2003-12-31: -815000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 294000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 2003-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -1109000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -815000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-05-013837.txt#9572 Input fundies:CapitalExpenditure: 294000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-05-013837.txt#9613 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 3.91 million Exact value Exact value: -3905000 USD 2004-01-01 – 2004-12-31: -3905000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 2004-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -3905000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3905000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-06-021118.txt#9149 The citation records this snapshot. The page link may show a newer release later.	−USD 747,000 Exact value Exact value: -747000 USD 2004-01-01 – 2004-12-31: -747000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 2004-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -747000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -747000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-06-021118.txt#9417 The citation records this snapshot. The page link may show a newer release later.	USD 131,000 Exact value Exact value: 131000 USD 2004-01-01 – 2004-12-31: 131000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 2004-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 131000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 131000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-06-021118.txt#9458 The citation records this snapshot. The page link may show a newer release later.	−USD 878,000 Calculation and evidence -747000 − 131000 USD Exact free cash flow: -878000 USD 2004-01-01 – 2004-12-31: -747000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 131000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 2004-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -878000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -747000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-06-021118.txt#9417 Input fundies:CapitalExpenditure: 131000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-06-021118.txt#9458 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 4.28 million Exact value Exact value: -4280000 USD 2005-01-01 – 2005-12-31: -4280000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 2005-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -4280000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4280000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8307 The citation records this snapshot. The page link may show a newer release later.	−USD 4.61 million Exact value Exact value: -4611000 USD 2005-01-01 – 2005-12-31: -4611000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 2005-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -4611000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4611000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8555 The citation records this snapshot. The page link may show a newer release later.	USD 49,000 Exact value Exact value: 49000 USD 2005-01-01 – 2005-12-31: 49000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 2005-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 49000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 49000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8596 The citation records this snapshot. The page link may show a newer release later.	−USD 4.66 million Calculation and evidence -4611000 − 49000 USD Exact free cash flow: -4660000 USD 2005-01-01 – 2005-12-31: -4611000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 49000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 2005-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -4660000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4611000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8555 Input fundies:CapitalExpenditure: 49000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8596 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 983,000 Exact value Exact value: -983000 USD 2006-01-01 – 2006-12-31: -983000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VANTAGEMED CORP · 2006-12-31 VANTAGEMED CORP (edgar:1099531) Net Income: -983000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -983000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8307 The citation records this snapshot. The page link may show a newer release later.	−USD 702,000 Exact value Exact value: -702000 USD 2006-01-01 – 2006-12-31: -702000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VANTAGEMED CORP · 2006-12-31 VANTAGEMED CORP (edgar:1099531) Operating Cash Flow: -702000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -702000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8555 The citation records this snapshot. The page link may show a newer release later.	USD 29,000 Exact value Exact value: 29000 USD 2006-01-01 – 2006-12-31: 29000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VANTAGEMED CORP · 2006-12-31 VANTAGEMED CORP (edgar:1099531) Capital Expenditure: 29000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8596 The citation records this snapshot. The page link may show a newer release later.	−USD 731,000 Calculation and evidence -702000 − 29000 USD Exact free cash flow: -731000 USD 2006-01-01 – 2006-12-31: -702000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 29000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VANTAGEMED CORP · 2006-12-31 VANTAGEMED CORP (edgar:1099531) Free cash flow: -731000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1099531?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -702000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8555 Input fundies:CapitalExpenditure: 29000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1099531/0001104659-07-024975.txt#8596 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

31 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001099531, 1099531, edgar:1099531

VANTAGEMED CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2006 2006-01-01 – 2006-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation